Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Psoriasis: HELP
Michel Gilliet
Based on 19 articles published since 2008
||||
Expertise Level
The expertise of Michel Gilliet ranks in the
  • Top 0.63%
  • ... of 37,573 published authors worldwide on Psoriasis
  • ... from 2008 through 2019
  • ... based on contributions to 19 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
Expert badge
similar to this:
 
Work Locations
Details
Most likely:    University of Lausanne      
2018
  • Department of Dermatology, Lausanne University Hospital CHUV, Lausanne, Switzerland. · Department of Dermatology, Lausanne University Hospital CHUV, Lausanne, Switzerland. · Pubmed 29349534
  • Department of Dermatology, University Hospital CHUV, Lausanne, 1011, Switzerland. · Department of Dermatology, University Hospital CHUV, Lausanne, 1011, Switzerland. · Department of Dermatology, University Hospital of Zurich, Zurich, 8091, Switzerland. · Department of Dermatology, University Hospital CHUV, Lausanne, 1011, Switzerland. · Pubmed 29295985
  • Institut Curie, Centre de Recherche, PSL Research University, Paris, France. · INSERM U932, Immunity and Cancer, Paris, France. · CNRS UMR 3244, ncRNA, Epigenetic, and Genome Fluidity, Université Pierre et Marie Curie, Paris, France. · Department of Dermatology, University Hospital CHUV, Lausanne, Switzerland. · CNRS UMR144, Paris, France. · Department of Biology, Ecole Normale Supérieure, PSL Research University, Paris, France. · IFOM Foundation, Institute FIRC of Molecular Oncology, Milan, Italy. · UMR7211 and Inflammation-Immunopathology-Biotherapy Departement (DHU i2B), Sorbonne Universités, UPMC Université de Paris, Paris, France. · Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier Pitié Salpétrière, Department of Internal Medicine and Clinical Immunology, National Reference Center for Autoimmune and Systemic Diseases, Paris, France. · AURA Paris Plaisance, Paris, France. · Department of Internal Medicine, National Referral Center for Rare Autoimmune and Systemic Diseases, Cochin Hospital, AP-HP, Université Paris Descartes, Paris, France. · Institut Curie, Centre de Recherche, PSL Research University, Paris, France. · INSERM U932, Immunity and Cancer, Paris, France. · CIC IGR-Curie 1428, Paris, France. · Pubmed 29203862
2017
  • Department of Dermatology and Allergology, Ludwig-Maximilian University Munich, Frauenlobstr. 9-11, Munich, Germany. · Department of Dental Medicine, Karolinska Institute, Alfred Nobels Allé 8, Huddinge, Sweden. · Department of Dermatology, Venereology and Allergy, Wroclaw Medical University, Chalubinskiego 1, Wroclaw, Poland. · Division of Clinical Pharmacology, Medizinische Klinik IV, Ludwig-Maximilian University Munich, Ziemssenstr. 1, Munich, Germany. · Department of Dermatology, University Hospital Düsseldorf, Moorenstrasse 5, Düsseldorf, Germany. · Department of Dermatology, University Hospital of Lausanne, CHUV University Hospital, Rue du Bugnon 46, Lausanne, Switzerland. · Department of Dermatology and Allergology, Philipps University Marburg, Marburg, Germany. · Pubmed 28422993
  • Department of Dermatology and Venereology, University Hospital of Lausanne, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland2Department of Dermatology and Venereology, Inselspital Bern University Hospital, University of Bern, Bern, Switzerland. · Department of Dermatology and Venereology, University Hospital of Lausanne, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland. · Department of Dermatology and Venereology, Inselspital Bern University Hospital, University of Bern, Bern, Switzerland. · Department of Dermatology and Venereology, Geneva University Hospitals, Geneva, Switzerland. · Pubmed 28122069
  • Department of Dermatology, University Hospital CHUV, Avenue de Beaumont 29, 1011, Lausanne, Switzerland. · Department of Dermatology, University Hospital CHUV, Avenue de Beaumont 29, 1011, Lausanne, Switzerland. · Pubmed 28063039
2015
  • 1] Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. [2] Department of Dermatology, Heinrich-Heine-University Medical Faculty, Düsseldorf, Germany. · Department of Dermatology, University Hospital CHUV, Lausanne, Switzerland. · Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Dermatology, Heinrich-Heine-University Medical Faculty, Düsseldorf, Germany. · 1] Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. [2] Department of Infectious Diseases, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Infectious Diseases, University Hospital CHUV, Lausanne, Switzerland. · School of Molecular and Cell Biology, University of Leeds, Leeds, UK. · Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas, USA. · Division of Dermatology, UCLA David Geffen School of Medicine, Los Angeles, California, USA. · Department of Infectious Diseases, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Respiratory, Inflammation and Autoimmunity, MedImmune, Gaithersburg, Maryland, USA. · Division of Biological and Environmental Sciences &Engineering, King Abdullah University of Science and Technology (KAUST), Thuwal, Kingdom of Saudi Arabia. · 1] Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. [2] Department of Dermatology, University Hospital CHUV, Lausanne, Switzerland. · Pubmed 26168081
2014
  • 1] Department of Infectious, Parasitic and Immunomediated Diseases, Istituto Superiore di Sanità, 00100 Rome, Italy [2] Department of Dermatology, University Hospital CHUV, 1011 Lausanne, Switzerland. · Dermatology Unit, NESMOS Department, Sapienza University of Rome, 00100 Rome, Italy. · Translational tumor immunology group, Ludwig center for cancer research of the University of Lausanne, Lausanne 1066, Switzerland. · TC Metrix, Epalinge 1066, Switzerland. · Department of Biology and Biotechnology 'C. Darwin', University La Sapienza, Rome, 00100 Italy. · Department of Dermatology, University Hospital CHUV, 1011 Lausanne, Switzerland. · Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Department of Dermatology, University Tor Vergata, 00100 Rome, Italy. · Department of Dermatology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Division of Rheumatology, Department of Clinical Medicine and Therapy, University La Sapienza, 00100 Rome, Italy. · Department of Dermatology, University Hospital of Zurich, 8091 Zurich, Switzerland. · 1] Dermatology Unit, NESMOS Department, Sapienza University of Rome, 00100 Rome, Italy [2] Translational tumor immunology group, Ludwig center for cancer research of the University of Lausanne, Lausanne 1066, Switzerland. · Pubmed 25470744
2015
  • Department of Dermatology, University Hospital of Lausanne CHUV, Lausanne, Switzerland; Department of Infectious, Parasitic and Immunomediated Diseases, Istituto Superiore di Sanità, Rome, Italy. · Pubmed 25332209
2013
  • Department of Dermatology, University Hospital CHUV, Lausanne, Switzerland. · Pubmed 24192530
2012
  • Department of Dermatology, Lausanne University Hospital of Lausanne, Lausanne, Switzerland. · Pubmed 22695287
Probable:    University of Texas Houston   Contact    
2015
  • 1] Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. [2] Department of Dermatology, Heinrich-Heine-University Medical Faculty, Düsseldorf, Germany. · Department of Dermatology, University Hospital CHUV, Lausanne, Switzerland. · Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Dermatology, Heinrich-Heine-University Medical Faculty, Düsseldorf, Germany. · 1] Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. [2] Department of Infectious Diseases, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Infectious Diseases, University Hospital CHUV, Lausanne, Switzerland. · School of Molecular and Cell Biology, University of Leeds, Leeds, UK. · Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas, USA. · Division of Dermatology, UCLA David Geffen School of Medicine, Los Angeles, California, USA. · Department of Infectious Diseases, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Respiratory, Inflammation and Autoimmunity, MedImmune, Gaithersburg, Maryland, USA. · Division of Biological and Environmental Sciences &Engineering, King Abdullah University of Science and Technology (KAUST), Thuwal, Kingdom of Saudi Arabia. · 1] Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. [2] Department of Dermatology, University Hospital CHUV, Lausanne, Switzerland. · Pubmed 26168081
2008
  • Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 18611439
2009
  • Department of Immunology, The University of Texas M.D. Anderson Cancer Center, TX 77030, USA. · Pubmed 19703986
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 19 total) written by Michel Gilliet about Psoriasis:

  • Psoriasis: from Pathogenesis to Targeted Therapies. 2018
  • TNF blockade induces a dysregulated type I interferon response without autoimmunity in paradoxical psoriasis. 2018
  • Diversification of human plasmacytoid predendritic cells in response to a single stimulus. 2018
  • Th17 micro-milieu regulates NLRP1-dependent caspase-5 activity in skin autoinflammation. 2017
  • Interleukin 23-Helper T Cell 17 Axis as a Treatment Target for Pityriasis Rubra Pilaris. 2017
  • Xenotransplantation Model of Psoriasis. 2017
  • Swiss S1 Guidelines on the Systemic Treatment of Psoriasis Vulgaris. 2016
  • [The skin microbiota: a colossus steps into the spotlight]. 2016
  • Superiority in Quality of Life Improvement of Biologics over Conventional Systemic Drugs in a Swiss Real-Life Psoriasis Registry. 2016
  • Efficacy and Survival of Systemic Psoriasis Treatments: An Analysis of the Swiss Registry SDNTT. 2016
Show List of Full Article Records
Google Searches

Learn more about Michel Gilliet using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Lausanne
University of Texas Houston
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Lausanne
2018
  • Department of Dermatology, Lausanne University Hospital CHUV, Lausanne, Switzerland. · Department of Dermatology, Lausanne University Hospital CHUV, Lausanne, Switzerland. · Pubmed 29349534
  • Department of Dermatology, University Hospital CHUV, Lausanne, 1011, Switzerland. · Department of Dermatology, University Hospital CHUV, Lausanne, 1011, Switzerland. · Department of Dermatology, University Hospital of Zurich, Zurich, 8091, Switzerland. · Department of Dermatology, University Hospital CHUV, Lausanne, 1011, Switzerland. · Pubmed 29295985
  • Institut Curie, Centre de Recherche, PSL Research University, Paris, France. · INSERM U932, Immunity and Cancer, Paris, France. · CNRS UMR 3244, ncRNA, Epigenetic, and Genome Fluidity, Université Pierre et Marie Curie, Paris, France. · Department of Dermatology, University Hospital CHUV, Lausanne, Switzerland. · CNRS UMR144, Paris, France. · Department of Biology, Ecole Normale Supérieure, PSL Research University, Paris, France. · IFOM Foundation, Institute FIRC of Molecular Oncology, Milan, Italy. · UMR7211 and Inflammation-Immunopathology-Biotherapy Departement (DHU i2B), Sorbonne Universités, UPMC Université de Paris, Paris, France. · Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier Pitié Salpétrière, Department of Internal Medicine and Clinical Immunology, National Reference Center for Autoimmune and Systemic Diseases, Paris, France. · AURA Paris Plaisance, Paris, France. · Department of Internal Medicine, National Referral Center for Rare Autoimmune and Systemic Diseases, Cochin Hospital, AP-HP, Université Paris Descartes, Paris, France. · Institut Curie, Centre de Recherche, PSL Research University, Paris, France. · INSERM U932, Immunity and Cancer, Paris, France. · CIC IGR-Curie 1428, Paris, France. · Pubmed 29203862
2017
  • Department of Dermatology and Allergology, Ludwig-Maximilian University Munich, Frauenlobstr. 9-11, Munich, Germany. · Department of Dental Medicine, Karolinska Institute, Alfred Nobels Allé 8, Huddinge, Sweden. · Department of Dermatology, Venereology and Allergy, Wroclaw Medical University, Chalubinskiego 1, Wroclaw, Poland. · Division of Clinical Pharmacology, Medizinische Klinik IV, Ludwig-Maximilian University Munich, Ziemssenstr. 1, Munich, Germany. · Department of Dermatology, University Hospital Düsseldorf, Moorenstrasse 5, Düsseldorf, Germany. · Department of Dermatology, University Hospital of Lausanne, CHUV University Hospital, Rue du Bugnon 46, Lausanne, Switzerland. · Department of Dermatology and Allergology, Philipps University Marburg, Marburg, Germany. · Pubmed 28422993
  • Department of Dermatology and Venereology, University Hospital of Lausanne, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland2Department of Dermatology and Venereology, Inselspital Bern University Hospital, University of Bern, Bern, Switzerland. · Department of Dermatology and Venereology, University Hospital of Lausanne, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland. · Department of Dermatology and Venereology, Inselspital Bern University Hospital, University of Bern, Bern, Switzerland. · Department of Dermatology and Venereology, Geneva University Hospitals, Geneva, Switzerland. · Pubmed 28122069
  • Department of Dermatology, University Hospital CHUV, Avenue de Beaumont 29, 1011, Lausanne, Switzerland. · Department of Dermatology, University Hospital CHUV, Avenue de Beaumont 29, 1011, Lausanne, Switzerland. · Pubmed 28063039
2015
  • 1] Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. [2] Department of Dermatology, Heinrich-Heine-University Medical Faculty, Düsseldorf, Germany. · Department of Dermatology, University Hospital CHUV, Lausanne, Switzerland. · Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Dermatology, Heinrich-Heine-University Medical Faculty, Düsseldorf, Germany. · 1] Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. [2] Department of Infectious Diseases, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Infectious Diseases, University Hospital CHUV, Lausanne, Switzerland. · School of Molecular and Cell Biology, University of Leeds, Leeds, UK. · Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas, USA. · Division of Dermatology, UCLA David Geffen School of Medicine, Los Angeles, California, USA. · Department of Infectious Diseases, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Respiratory, Inflammation and Autoimmunity, MedImmune, Gaithersburg, Maryland, USA. · Division of Biological and Environmental Sciences &Engineering, King Abdullah University of Science and Technology (KAUST), Thuwal, Kingdom of Saudi Arabia. · 1] Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. [2] Department of Dermatology, University Hospital CHUV, Lausanne, Switzerland. · Pubmed 26168081
2014
  • 1] Department of Infectious, Parasitic and Immunomediated Diseases, Istituto Superiore di Sanità, 00100 Rome, Italy [2] Department of Dermatology, University Hospital CHUV, 1011 Lausanne, Switzerland. · Dermatology Unit, NESMOS Department, Sapienza University of Rome, 00100 Rome, Italy. · Translational tumor immunology group, Ludwig center for cancer research of the University of Lausanne, Lausanne 1066, Switzerland. · TC Metrix, Epalinge 1066, Switzerland. · Department of Biology and Biotechnology 'C. Darwin', University La Sapienza, Rome, 00100 Italy. · Department of Dermatology, University Hospital CHUV, 1011 Lausanne, Switzerland. · Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Department of Dermatology, University Tor Vergata, 00100 Rome, Italy. · Department of Dermatology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Division of Rheumatology, Department of Clinical Medicine and Therapy, University La Sapienza, 00100 Rome, Italy. · Department of Dermatology, University Hospital of Zurich, 8091 Zurich, Switzerland. · 1] Dermatology Unit, NESMOS Department, Sapienza University of Rome, 00100 Rome, Italy [2] Translational tumor immunology group, Ludwig center for cancer research of the University of Lausanne, Lausanne 1066, Switzerland. · Pubmed 25470744
2015
  • Department of Dermatology, University Hospital of Lausanne CHUV, Lausanne, Switzerland; Department of Infectious, Parasitic and Immunomediated Diseases, Istituto Superiore di Sanità, Rome, Italy. · Pubmed 25332209
2013
  • Department of Dermatology, University Hospital CHUV, Lausanne, Switzerland. · Pubmed 24192530
2012
  • Department of Dermatology, Lausanne University Hospital of Lausanne, Lausanne, Switzerland. · Pubmed 22695287
University of Texas Houston
2015
  • 1] Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. [2] Department of Dermatology, Heinrich-Heine-University Medical Faculty, Düsseldorf, Germany. · Department of Dermatology, University Hospital CHUV, Lausanne, Switzerland. · Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Dermatology, Heinrich-Heine-University Medical Faculty, Düsseldorf, Germany. · 1] Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. [2] Department of Infectious Diseases, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Infectious Diseases, University Hospital CHUV, Lausanne, Switzerland. · School of Molecular and Cell Biology, University of Leeds, Leeds, UK. · Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas, USA. · Division of Dermatology, UCLA David Geffen School of Medicine, Los Angeles, California, USA. · Department of Infectious Diseases, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Respiratory, Inflammation and Autoimmunity, MedImmune, Gaithersburg, Maryland, USA. · Division of Biological and Environmental Sciences &Engineering, King Abdullah University of Science and Technology (KAUST), Thuwal, Kingdom of Saudi Arabia. · 1] Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. [2] Department of Dermatology, University Hospital CHUV, Lausanne, Switzerland. · Pubmed 26168081
2008
  • Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 18611439
2009
  • Department of Immunology, The University of Texas M.D. Anderson Cancer Center, TX 77030, USA. · Pubmed 19703986
3 Other Locations Show
Yearly article counts 033441110011
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.